Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

IWWM-11 2022 | The impact of booster vaccinations on SARS-CoV-2 antibody levels in patients with WM

Lee Greenberger • 31 Oct 2022

IWWM-11 2022

Lymphoma Non-Hodgkin Lymphoma Rare Diseases Waldenström’s Macroglobulinemia Vaccines

Lee Greenberger, PhD, Leukemia & Lymphoma Society, New York, NY, discusses the impact of COVID-19 booster vaccinations on serum antibody levels in patients with Waldenström’s macroglobulinemia (WM), and further emphasizes the precautions that should be taken by these immunocompromised patients to prevent infection. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Addressing cardiovascular AEs associated with BTKi treatment in patients with CLL

Lee Greenberger • 9 Dec 2023

Real-world incidence of ibrutinib-related cardiotoxicity in CLL: insights from the LLS registry

Lee Greenberger • 9 Dec 2023

COVID-19 vaccination response in patients with hematologic malignancies from the LLS Registry

Lee Greenberger • 11 Dec 2022

The importance of monitoring COVID-19 in patients with Waldenström’s macroglobulinemia

Lee Greenberger • 31 Oct 2022

Related Videos

Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS

Sridhar Chaganti • 16 Apr 2024

The role of CAR-T therapy for lymphoma in 2024: expert session highlights

Sridhar Chaganti • 16 Apr 2024

Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH

Carlo Dufour • 15 Apr 2024

Promising novel immunotherapeutic approaches in lymphoma

Gloria Iacoboni • 15 Apr 2024